Cat.#: ACPP-1242
Despition | MC3 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
SIZE | 250 µg |
Applications | Immunodepletion & Immunocompetition assay |
Storage | Store at -20⁰C for long term |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1826 | Human CRYGN Protein (AC1826) | 5 µg | inquiry |
ACPP-1618 | Human SYT11 Protein (AC1618) | 2 µg | inquiry |
ACPP-1368 | KCNJ2 Blocking Peptide (AC1368) | 250 µg | inquiry |
ACPP-1648 | Human RAMP1 Protein (AC1648) | 2 µg | inquiry |
ACPP-1505 | Human CRYGD Protein (AC1505) | 5 µg | inquiry |
ACPP-1833 | Human CRMP1 Protein (AC1833) | 5 µg | inquiry |
ACPP-1387 | Human ARC Protein (AC1387) | 1 µg | inquiry |
ACPP-1513 | Human FGFR2 Protein (AC1513) | 2 µg | inquiry |
ACPP-1847 | Human GFRA3 Protein (AC1847) | 5 µg | inquiry |
ACPP-1024 | Recombinant Human FGF2 Protein (mutated Q65I + C96S + N111G). (AC1024) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.